National Institute of Neurological Disorders and Stroke Notice of Closed Meetings, 60407 [2017-27329]
Download as PDF
<![CDATA[
Federal Register / Vol. 82, No. 243 / Wednesday, December 20, 2017 / Notices
sradovich on DSK3GMQ082PROD with NOTICES
immunotherapy using autologous (meaning
one individual is both the donor and the
recipient) T cells transfected with a retroviral
vector (including lentiviral vectors), wherein
the vector expresses a CAR having:
(1) a single antigen specificity; and
(2) comprising at least:
(a) the complementary determining region
(CDR) sequences of the anti-CD30 antibody
known as 5F11; and
(b) a T cell signaling domain;
for the prophylaxis and treatment of CD30expressing human cancers.’’
This technology discloses the
development of chimeric antigen
receptors that recognize the CD30
protein (also known as tumor necrosis
factor receptor superfamily member 8
(TNFRSF8)). CD30 is expressed on the
cell surface of several rare forms of
cancer, including Hodgkin lymphoma
(HL), Non-Hodgkin’s Lymphoma (NHL),
diffuse large B cell lymphoma (DLBCL),
peripheral T cell lymphoma not
otherwise specified (PTCL–NOS),
anaplastic large cell lymphoma (ALCL),
and angioimmunoblastic T cell
lymphoma (AITL). The development of
a new therapeutic targeting CD30 will
benefit public health by offering up a
treatment for these rare cancers in
instances when conventional first line
therapies are ineffective.
This notice is made in accordance
with 35 U.S.C. 209 and 37 CFR part 404.
The prospective exclusive license will
be royalty bearing, and the prospective
exclusive license may be granted unless
within fifteen (15) days from the date of
this published notice, the National
Cancer Institute receives written
evidence and argument that establishes
that the grant of the license would not
be consistent with the requirements of
35 U.S.C. 209 and 37 CFR part 404.
In response to this Notice, the public
may file comments or objections.
Comments and objections, other than
those in the form of a completed license
application, will not be treated
confidentially, and may be made
publicly available.
License applications submitted in
response to this Notice will be
presumed to contain business
confidential information and any release
of information in these license
applications will be made only as
required and upon a request under the
Freedom of Information Act, 5 U.S.C.
552.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Institute of Neurological
Disorders and Stroke Notice of Closed
Meetings
Proposed Collection; 60-Day Comment
Request Division of Cancer
Epidemiology and Genetics Fellowship
Program and Summer Student
Applications (DCEG) (National Cancer
Institute)
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke
Technologies for Large-Scale Recording and
Modulation in the Nervous System.
Date: January 18–19, 2018.
Time: 8:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Alexandria Old Town, 1767
King Street, Alexandria, VA 22314.
Contact Person: Ernest Lyons, Ph.D.,
Scientific Review Officer; Scientific Review
Branch; NINDS/NIH/DHHS; Neuroscience
Center; 6001 Executive Blvd., Suite 3204,
MSC 9529, Bethesda, MD 20892–9529; 301–
496–4056; lyonse@ninds.nih.gov.
Name of Committee: Neurological Sciences
Training Initial Review Group; NST–1
Subcommittee.
Date: January 29–30, 2018.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Alexandria Old Town, 1767
King Street, Alexandria, VA 22314.
Contact Person: William Benzing, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3204,
MSC 9529, Bethesda, MD 20892–9529, 301–
496–0660, benzingw@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: December 8, 2017.
Richard U. Rodriguez,
Associate Director, Technology Transfer
Center, National Cancer Institute.
Dated: December 14, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–27416 Filed 12–19–17; 8:45 am]
[FR Doc. 2017–27329 Filed 12–19–17; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
VerDate Sep<11>2014
21:36 Dec 19, 2017
Jkt 244001
60407
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
National Institutes of Health.
Notice.
AGENCY:
ACTION:
In compliance with the
requirement of the Paperwork
Reduction Act of 1995 to provide
opportunity for public comment on
proposed data collection projects, the
National Cancer Institute (NCI) will
publish periodic summaries of propose
projects to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 60 days of the date of this
publication.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments, submit
comments in writing, or request more
information on the proposed project,
contact: Jackie Lavigne, Ph.D., M.P.H.,
Chief, Office of Education, Division of
Cancer Epidemiology and Genetics,
9609 Medical Center Drive, MSC,
Bethesda, Maryland 20892 or call nontoll-free number 240.276.7237or Email
your request, including your address to:
lavignej@mail.nih.gov. Formal requests
for additional plans and instruments
must be requested in writing.
SUPPLEMENTARY INFORMATION: Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 requires: Written
comments and/or suggestions from the
public and affected agencies are invited
to address one or more of the following
points: (1) Whether the proposed
collection of information is necessary
for the proper performance of the
function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimize’s
the burden of the collection of
information on those who are to
respond, including the use of
appropriate automated, electronic,
mechanical, or other technological
SUMMARY:
E:\FR\FM\20DEN1.SGM
20DEN1
]]>Agencies
[Federal Register Volume 82, Number 243 (Wednesday, December 20, 2017)]
[Notices]
[Page 60407]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-27329]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Neurological Disorders
and Stroke Technologies for Large-Scale Recording and Modulation in
the Nervous System.
Date: January 18-19, 2018.
Time: 8:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Alexandria Old Town, 1767 King Street, Alexandria,
VA 22314.
Contact Person: Ernest Lyons, Ph.D., Scientific Review Officer;
Scientific Review Branch; NINDS/NIH/DHHS; Neuroscience Center; 6001
Executive Blvd., Suite 3204, MSC 9529, Bethesda, MD 20892-9529; 301-
496-4056; [email protected].
Name of Committee: Neurological Sciences Training Initial Review
Group; NST-1 Subcommittee.
Date: January 29-30, 2018.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Alexandria Old Town, 1767 King Street, Alexandria,
VA 22314.
Contact Person: William Benzing, Ph.D., Scientific Review
Officer, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3204, MSC 9529, Bethesda, MD
20892-9529, 301-496-0660, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS)
Dated: December 14, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-27329 Filed 12-19-17; 8:45 am]
BILLING CODE 4140-01-P
